Breaking News

Bruker Introduces Label-Free Characterization Platform for Nanoscale Bioparticles

iNTApharma provides single-particle sensitivity for quantitative analysis in native aqueous media.

Author Image

By: Patrick Lavery

Content Marketing Editor

Bruker Corporation is launching iNTApharma, a label-free characterization platform featuring single-particle sensitivity to quantitatively analyze nanoscale bioparticles. Evaluating these particles in native aqueous media, the platform can provide size and concentration measurements in just minutes. This, according to Bruker, supports research, therapy development, and quality control workflows requiring direct assessment without labeling or chemical modifications. Importance of Nanoscale ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters